期刊文献+

Shunt products of aminoansamycins from aas1 overexpressed mutant strain of Streptomyces sp.S35

原文传递
导出
摘要 Constitutively expression of the pathway-specific activators is an effective method to activate silent gene clusters and improve natural product production.In this study,nine shunt products of aminoansamycins(1-9)were identified from a recombinant mutant strain S35-LAL by overexpressed the large-ATP-binding regulator of the LuxR family(LAL)gene aas1 in Streptomyces sp.S35.All the compounds showed no anti-microbial,anti-T3 SS and cytotoxic activities.
出处 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2020年第12期952-956,共5页 中国天然药物(英文版)
基金 supported by the National Natural Science Foundation of China(Nos.81673317,81530091,and31570039) the Open Funding Project of State Key Laboratory of Microbial Metabolite Funding(No.MMLKF17-09) the Program for Changjiang Scholars and Innovative Research Team in University(No.IRT_17R68)。
  • 相关文献

参考文献1

二级参考文献28

  • 1Kupchan S M, Komoda Y, Court W A, et al. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J Am Chem Soc, 1972, 94:1354-1356.
  • 2Higashide E, Asai M, Ootsu K, et al. Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia. Nature, 1977, 270:721-722.
  • 3Dhillon S. Everolimus in combination with exemestane: a review of its use in the treatment of patients with postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer. Drugs, 2013, 73:475-485.
  • 4Kim C G, Yu T W, Fryhle C B, et al. 3-Amino-5-hydroxybenzoic acid synthase, the terminal enzyme in the formation of the precursor of mCTN units in rifamycin and related antibiotics. J Biol Chem, 1998, 273:6030-6040.
  • 5Watanabe K, Rude M A, Walsh C T, et al. Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli. Proc Natl Acad Sci USA, 2003, 100:9774-9778.
  • 6Yu T W, Bai L Q, Clade D, et al. The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum. Proc Natl Acad Sci USA, 2002, 99:7968-7973.
  • 7Wu Y, Kang Q, Shang G, et al. N-methylation of the amide bond by methyltransferase asmlO in ansamitocin biosynthesis. Chembiochem, 2011, 12:1759-1766.
  • 8Li Y, Zhao P, Kang Q, et al. Dual carbamoylations on the polyketide and glycosyl moiety by asm21 result in extended ansamitocin biosynthesis. Chem Biol, 2011, 18:1571-1580.
  • 9Spiteller P, Bai L, Shang G, et al. The post-polyketide synthase modification steps in the biosynthesis of the antitumor agent ansamitocin by Actinosynnema pretiosum. J Am Chem Soc, 2003, 125:14236-14237.
  • 10Bandi S, Kim Y, Chang Y K, et al. Construction of asm2 deletion mutant of Actinosynnerna pretiosum and medium optimization for ansamitocin P-3 production using statistical approach. J Microbiol Biotechn, 2006, 16:1338-1346.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部